HCA Healthcare closed at $510.70 on Nov 4, up 10.34%, 6.3% below its 52-week closing high. Volume of 3.4M shares was 2.66× its 20-day average (well above normal).
Split-adjusted performance: +18.2% over one month, +18.9% over six months, +10.6% over one year.
In the quarter ended Sep 30, 2026, revenue was $19.85B, up 3.6% from a year earlier, with a net margin of 8.0%.
Short interest was 4.9M shares at the Oct 15 settlement (2.8% of float, 4.6 days to cover).
After its Oct 27 report (EPS beat estimates by 8.6%), the stock moved -0.4% from the close before to the close after.